Abstract
Screening of small-molecule libraries is an important aspect of probe and drug discovery science. Numerous authors have suggested that bioactive natural products are attractive starting points for such libraries because of their structural complexity and sp3-rich character. Here, we describe the construction of a screening library based on representative members of four families of biologically active alkaloids (Stemonaceae, the structurally related cyclindricine and lepadiformine families, lupin and Amaryllidaceae). In each case, scaffolds were based on structures of the naturally occurring compounds or a close derivative. Scaffold preparation was pursued following the development of appropriate enabling chemical methods. Diversification provided 686 new compounds suitable for screening. The libraries thus prepared had structural characteristics, including sp3 content, comparable to a basis set of representative natural products and were highly rule-of-five compliant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70, 461–477 (2007).
Butler, M. S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep. 25, 475–516 (2008).
Paterson, I. & Anderson, E. A. Chemistry. The renaissance of natural products as drug candidates. Science 310, 451–453 (2005).
Ganesan, A. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol. 12, 306–317 (2008).
Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3–25 (1997).
Boldi, A. M. Libraries from natural product-like scaffolds. Curr. Opin. Chem. Biol. 8, 281–286 (2004).
Thomas, G. L. & Johannes, C. W. Natural product-like synthetic libraries. Curr. Opin. Chem. Biol. 15, 516–522 (2011).
Camp, D., Davis, R. A., Evans-Illidge, E. A. & Quinn, R. J. Guiding principles for natural product drug discovery. Future Med. Chem. 4, 1067–1084 (2012).
Lachance, H., Wetzel, S., Kumar, K. & Waldmann, H. Charting, navigating, and populating natural product chemical space for drug discovery. J. Med. Chem. 55, 5989–6001 (2012).
Zuegg, J. & Cooper, M. A. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening. Curr. Top. Med. Chem. 12, 1500–1513 (2012).
Njardarson, J. T., Gaul, C., Shan, D., Huang, X-Y. & Danishefsky, S. J. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure–activity studies of (+)-migrastatin. J. Am. Chem. Soc. 126, 1038–1040 (2004).
Szpilman, A. M. & Carreira, E. M. Probing the biology of natural products. Molecular editing by diverted total synthesis. Angew. Chem. Int. Ed. 49, 9592–9628 (2010).
Wetzel, S., Bon, R. S., Kumar, K. & Waldmann, H. Biology-oriented synthesis. Angew. Chem. Int. Ed. 50, 10800–10826 (2011).
Burke, M. D. & Schreiber, S. L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Ed. 43, 46–58 (2004).
Huigens, R. W. et al. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nature Chem. 5, 195–202 (2013).
Kim, Y. K. et al. Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. J. Am. Chem. Soc. 126, 14740–14745 (2004).
Shelat, A. A. & Guy, R. K. Scaffold composition and biological relevance of screening libraries. Nature Chem. Biol. 3, 442–446 (2007).
Lovering, F., Bikker, J. & Humblet, C. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 52, 6752–6756 (2009).
Clemons, P. A. et al. Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections. Proc. Natl Acad. Sci. USA 108, 6817–6822 (2011).
Lovering, F. Escape from flatland 2: complexity and promiscuity. MedChemComm 4, 515–519 (2013).
Nandy, J. P. et al. Advances in solution- and solid-phase synthesis toward the generation of natural product-like libraries. Chem. Rev. 109, 1999–2060 (2009).
MacLellan, P. & Nelson, A. A conceptual framework for analysing and planning synthetic approaches to diverse lead-like scaffolds. Chem. Commun. 49, 2383–2393 (2013).
Evans, B. E. et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 31, 2235–2246 (1988).
DeSimone, R. W., Currie, K. S., Mitchell, S. A., Darrow, J. W. & Pippin, D. A. Privileged structures: applications in drug discovery. Comb. Chem. High T. Scr. 7, 473–493 (2004).
Costantino, L. & Barlocco, D. Privileged structures as leads in medicinal chemistry. Curr. Med. Chem. 13, 65–85 (2006).
Duarte, C. D., Barreiro, E. J. & Fraga, C. A. M. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini-Rev. Med. Chem. 7, 1108–1119 (2007).
Costantino, L. & Barlocco, D. Privileged structures as leads in medicinal chemistry. Front. Med. Chem. 5, 381–422 (2010).
Verma, A. et al. Nitrogen-containing privileged structures and their solid phase combinatorial synthesis. Comb. Chem. High T. Scr. 16, 345–393 (2013).
Frankowski, K. J. et al. Synthesis and receptor profiling of Stemona alkaloid analogues reveal a potent class of sigma ligands. Proc. Natl Acad. Sci. USA 108, 6727–6732 (2011).
Pilli, R. A., Rosso, G. B. & de Oliveira, M. d. C. F. The Stemona alkaloids. Alkaloids 62, 77–173 (2005).
Pilli, R. A., Rosso, G. B. & de Oliveira, M. d. C. F. The chemistry of Stemona alkaloids: an update. Nat. Prod. Rep. 27, 1908–1937 (2010).
Weinreb, S. M. Studies on total synthesis of the cylindricine/fasicularin/ lepadiformine family of tricyclic marine alkaloids. Chem. Rev. 106, 2531–2549 (2006).
Gericke, N. & Viljoen, A. M. Sceletium—a review update. J. Ethnopharm. 119, 653–663 (2008).
Perez, E. G., Mendez-Galvez, C. & Cassels, B. K. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors. Nat. Prod. Rep. 29, 555–567 (2012).
Daly, J. W. Nicotinic agonists, antagonists, and modulators from natural sources. Cell. Mol. Neurobiol. 25, 513–552 (2005).
Wrobleski, A., Coombs, T. C., Huh, C. W., Li, S-W. & Aubé, J. The Schmidt reaction. Org. React. 78, 1–320 (2012).
Zeng, Y., Reddy, D. S., Hirt, E. & Aube, J. Domino reactions that combine an azido–Schmidt ring expansion with the Diels–Alder reaction. Org. Lett. 6, 4993–4995 (2004).
Gracias, V., Frank, K. E., Milligan, G. L. & Aubé, J. Ring expansion by in situ tethering of hydroxy azides to ketones: the Boyer reaction. Tetrahedron 53, 16241–16252 (1997).
Smith, B. T., Wendt, J. A. & Aube, J. First asymmetric total synthesis of (+)-sparteine. Org. Lett. 4, 2577–2579 (2002).
Meyer, A. M., Katz, C. E., Li, S-W., Vander Velde, D. & Aube?, J. A tandem Prins/Schmidt reaction approach to marine alkaloids: formal and total syntheses of lepadiformines A and C. Org. Lett. 12, 1244–1247 (2010).
Fenster, E. et al. Three-component synthesis of 1,4-diazepin-5-ones and the construction of γ-turn-like peptidomimetic libraries. J. Comb. Chem. 10, 230–234 (2008).
Trost, B. M. & Bogdanowicz, M. J. New synthetic reactions. X. Versatile cyclobutanone (spiroannelation) and γ-butyrolactone (lactone annelation) synthesis. J. Am. Chem. Soc. 95, 5321–5334 (1973).
Li, X. & Danishefsky, S. J. Cyclobutenone as a highly reactive dienophile: expanding upon Diels–Alder paradigms. J. Am. Chem. Soc. 132, 11004–11005 (2010).
Xue, L., Stahura, F. & Bajorath, J. in Chemoinformatics Vol. 275 (ed. Jürgen Bajorath) Ch. 9, 279–289 (Humana, 2004).
Kopp, F., Stratton, C. F., Akella, L. B. & Tan, D. S. A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion. Nature Chem. Biol. 8, 358–365 (2012).
Sauer, W. H. B. & Schwarz, M. K. Molecular shape diversity of combinatorial libraries: a prerequisite for broad bioactivity. J. Chem. Inf. Comput. Sci. 43, 987–1003 (2003).
Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615–2623 (2002).
Bauer, R. A., Wurst, J. M. & Tan, D. S. Expanding the range of ‘druggable’ targets with natural product-based libraries: an academic perspective. Curr. Opin. Chem. Biol. 14, 308–314 (2010).
Acknowledgements
The authors thank P. Porubsky and B. Neuenswander for purification of library compounds. The authors also acknowledge financial support from the US Institute of General Medical Sciences (P41 GM089164, Pilot-scale Libraries Initiative; 5P50GM069663, KU Chemical Methodologies and Library Development Center) and an NSF-MRI grant (CHE-0923449) for the purchase of an X-ray diffractometer.
Author information
Authors and Affiliations
Contributions
M.C.M., J.N.P., D.R., G.S. and J.A. designed the experiments and analysed the data. M.C.M., J.N.P., D.R. and G.S. performed the synthesis and characterization. J.L.W. and M.C.M. performed the cheminformatic analysis and V.W.D. performed and analysed the X-ray structures. M.C.M. and J.A. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information
Supplementary information (PDF 0 kb)
Supplementary information
Supplementary information (XLSX 338 kb)
Supplementary information
Crystallographic data for compound 3b (CIF 15 kb)
Supplementary information
Crystallographic data for compound 3c (CIF 15 kb)
Supplementary information
Crystallographic data for compound 3d (CIF 28 kb)
Supplementary information
Crystallographic data for compound 29d(2) (CIF 19 kb)
Supplementary information
Crystallographic data for compound 29c(8) (CIF 20 kb)
Supplementary information
Crystallographic data for compound 42(13) (CIF 17 kb)
Supplementary information
Crystallographic data for compound 43b(23) (CIF 19 kb)
Supplementary information
Crystallographic data for compound S3b (CIF 15 kb)
Supplementary information
Crystallographic data for compound S3c (CIF 27 kb)
Supplementary information
Crystallographic data for compound S3d (CIF 38 kb)
Supplementary information
Crystallographic data for compound S6 (CIF 19 kb)
Supplementary information
Crystallographic data for compound S14 (CIF 16 kb)
Rights and permissions
About this article
Cite this article
McLeod, M., Singh, G., Plampin, J. et al. Probing chemical space with alkaloid-inspired libraries. Nature Chem 6, 133–140 (2014). https://doi.org/10.1038/nchem.1844
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchem.1844
This article is cited by
-
Catalytic 4-exo-dig carbocyclization for the construction of furan-fused cyclobutanones and synthetic applications
Nature Communications (2023)
-
A general strategy for diversifying complex natural products to polycyclic scaffolds with medium-sized rings
Nature Communications (2019)
-
Reagent-controlled regiodivergent ring expansions of steroids
Nature Communications (2018)
-
Functional and informatics analysis enables glycosyltransferase activity prediction
Nature Chemical Biology (2018)
-
A ligand-directed divergent catalytic approach to establish structural and functional scaffold diversity
Nature Communications (2017)